Free CME

  • FREE

    CME: Medical and nutritional management of eosinophilic esophagitis in adolescents and adults: therapeutic updates and best practices

    Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease characterized by clinical features of esophageal dysfunction and eosinophil inflammation. EoE is mediated by type 2 helper T cell activity and precipitated primarily by dietary antigens. It may affect people of all ages and races, but the prevalence is highest amongst middle-aged Caucasian males. Approximately 30 out of every 100,000 adults in the U.S. are thought to have the condition.

    By the end of the session the participant will be able to:

    • Describe the patholophysiology of EoE in adults and adolescents such that it informs treatment mechanisms
    • Describe the clinical presentation, complications associated with, and diagnosis EoE in adults and adolescents.
    • Identify current drug treatment options and dietary strategies available for the management of EoE, including strengths and weaknesses of each, and apply them to patient cases using evidence-based medicine.
    • Identify issues with current practices for EoE and strategies to address them.

    Target Audience:

    The following healthcare professionals: allergists, immunologists, pediatricians, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who specialize in the aforementioned fields; and any other healthcare professionals with an interest in or who may clinically encounter patients with EoE.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 2/15/2020
    • Expiration of CME credit: 2/15/2022
  • FEATURED
    FREE

    CME: Coronavirus disease 2019 (COVID-19) preparedness, facts, and management

    In response to the COVID-19 public health emergency, the Centers for Disease Control and Prevention (CDC) has prepared several related informational materials. This activity consists of information that the CDC believes would be immediately useful to healthcare professionals.

    Target Audience: Healthcare professionals who may encounter patients exposed to the 2019 novel coronavirus (2019-nCoV) or patients with confirmed or at risk of developing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 0.50
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 3/10/2020
    • Expiration of CME credit: 3/10/2021
  • FREE

    CME: Hemodynamics – Where are We Now?

    Goal-directed therapy (GDT) has been taken as the gospel in critical care since the publication of Rivers et al.’s seminal paper on the topic demonstrating a mortality benefit in patients with severe sepsis and related shock back in late 2001, whose protocols were soon embraced and became ensconced in practice as standards of care, overlapping with other, high-acuity areas of medical specialty like surgery and emergency medicine. However, these initially results later became more mixed and equivocal on the whole when balanced in the context of more recent literature.

    By the end of the session the participant will be able to:

    • Describe the present methods of fluid assessment
    • Describe the present methods of hemodynamic monitoring
    • Given patient cases, reason your approach to fluid management under various clinical circumstances

    Target Audience:

    This program has been designed for a multidisciplinary physician and nurse audience including: ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 12/9/19
    • Expiration of CME credit: 12/9/21
  • FREE

    CME: New Trends in Hemodynamics: Dynamic Assessments

    Goal-directed therapy (GDT) has been taken as the gospel in critical care since the publication of Rivers et al.’s seminal paper on the topic demonstrating a mortality benefit in patients with severe sepsis and related shock back in late 2001, whose protocols were soon embraced and became ensconced in practice as standards of care, overlapping with other, high-acuity areas of medical specialty like surgery and emergency medicine. However, these initially results later became more mixed and equivocal on the whole when balanced in the context of more recent literature.

    By the end of the session the participant will be able to:

    • Describe the risks of over- and under-resuscitation
    • Describe the present methods of fluid assessment
    • Describe the present methods of hemodynamic monitoring
    • Given patient cases, reason your approach to fluid management under various clinical circumstances

    Target Audience:

    This program has been designed for a multidisciplinary physician and nurse audience including: ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 12/9/19
    • Expiration of CME credit: 12/9/21
  • FREE

    CME: Applications in Hemodynamics – Taking Us from Here to the Future: Clinical Applications

    Goal-directed therapy (GDT) has been taken as the gospel in critical care since the publication of Rivers et al.’s seminal paper on the topic demonstrating a mortality benefit in patients with severe sepsis and related shock back in late 2001, whose protocols were soon embraced and became ensconced in practice as standards of care, overlapping with other, high-acuity areas of medical specialty like surgery and emergency medicine. However, these initially results later became more mixed and equivocal on the whole when balanced in the context of more recent literature.

    By the end of the session the participant will be able to:

    • Given patient cases, reason your approach to fluid management under various clinical circumstances
    • Given patient cases, balance volume with vasoactive therapy in your hemodynamic stewardship of the patient

    Target Audience:

    This program has been designed for a multidisciplinary physician and nurse audience including: ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 12/9/19
    • Expiration of CME credit: 12/9/21
  • FREE

    CME: Updates in the management of insomnia: therapeutic updates and optimizing treatment

    Insomnia is defined by the dissatisfaction of sleep quality or quantity characterized by having difficulty falling asleep, staying asleep, waking too early, or a combination of these. It is defined as chronic if the condition persists for three months, despite the opportunity for sleep or eradication of external stimulus. Insomnia affects people of all ages, though the likelihood of developing insomnia increases with age: reporting one-third of the adult population having been affected by at least one symptom of insomnia.

    By the end of the session the participant will be able to:

    • Describe the pathophysiology of insomnia such that it might inform treatment mechanisms
    • Identify the currently available and emerging pharmacotherapeutic treatments for management of insomnia and apply them to patient cases using evidence-based medicine
    • Evaluate a treatment plan for a specific patient with insomnia to optimize safety and efficacy, suggesting modifications for improvement
    • Describe barriers to care associated with treating patients with insomnia

    Target Audience: The following HCPs: neurologists, psychiatrists, sleep medicine specialists, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in the aforementioned areas of specialty; and those who otherwise have an interest in or commonly care for or clinically encounter patients with insomnia.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 10/18/2019
    • Expiration of CME credit: 10/18/2021
  • FREE

    CME: Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents: Updates from APA 2019

    ADHD is a common neuropsychiatric disorder, estimated to affect 7.2% of school age children worldwide and 11% in the US. The presence of the disorder is often not detectable until school workload increases, and it has a significant impact on child and adolescent development, health, education, and family situations. There is evidence of a wide variability in clinicians’ ability to diagnose ADHD, suggesting opportunities for improvement and a gap in care that might be remedied by CME.

    By the end of the session the participant will be able to:

    • Summarize the most impactful findings presented at the APA 2019 meeting relating to pediatric ADHD related to disease diagnosis and apply them to patient cases.
    • Summarize the most impactful findings presented at the APA 2019 meeting relating to pediatric ADHD related to evaluation of degree therapeutic success and apply them to patient cases.
    • Summarize the most impactful findings presented at the APA 2019 meeting relating to pediatric ADHD related to emerging therapies and apply them to patient cases.
    • Summarize the most impactful findings presented at the APA 2019 meeting relating to pediatric ADHD related to quantifying benefit and risk of disease progression and apply them to patient cases.

    Target Audience:

    The following healthcare professionals: psychiatrists, primary care physicians, pediatricians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in psychiatry; and any other healthcare professionals with an interest in or who clinically encounter pediatric patients with ADHD.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 10/6/19
    • Expiration of CME credit: 10/6/21
  • FREE

    CME: Attention Deficit Hyperactivity Disorder (ADHD) in Adults: Updates from APA 2019

    ADHD is a common neuropsychiatric disorder, affecting more than 2-3% of adults in the United States. ADHD is characterized by inattentive and/or hyperactive symptoms. Inattentive symptoms include inattention, distractibility and procrastination whereas hyperactive symptoms include impatience, restlessness, and impulsiveness. The presence of the disorder has a significant impact on health, education, and family situations.

    By the end of the session the participant will be able to:

    • Summarize the most impactful findings presented at the APA 2019 meeting relating to ADHD in adults related to disease diagnosis and apply them to patient cases.
    • Summarize the most impactful findings presented at the APA 2019 meeting relating to ADHD in adults related to evaluation of degree therapeutic success and apply them to patient cases.
    • Summarize the most impactful findings presented at the APA 2019 meeting relating to ADHD in adults related to emerging therapies and apply them to patient cases.
    • Summarize the most impactful findings presented at the APA 2019 meeting relating to ADHD in adults related to quantifying benefit and risk of disease progression and apply them to patient cases.

    Target Audience:

    The following healthcare professionals: psychiatrists, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in psychiatry; and any other healthcare professionals with an interest in or who clinically encounter pediatric patients with ADHD.

    See full details chevron_right
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 10/1/2019
    • Expiration of CME credit: 10/1/2021
  • FREE

    CME: Updates in vaccine-preventable diseases: meningococcal meningitis

    Meningococcal disease is a potentially severe bacterial infection caused by Neisseria meningitidis that may lead to serious sequelae and death in some even with appropriate treatment. N. meningitidis is a leading cause of bacterial meningitis and sepsis in the United States. Since the peak of the disease in the late 1990s, the incidence has declined annually and was at historic low rate of 0.11 per 100,000 population (349 cases) in the year 2017. Among the identified bacterial serogroups, B, C, and Y cause the majority of cases in the United States. Sixty percent of cases among patients 0-59 months and 50% of cases among 17-23 years of age are caused by serogroup B. Seventy-three percent of all cases among eleven year old or more are caused by serogroups C, W, or Y.

    By the end of the session the participant will be able to:

    • Recall epidemiology, clinical features, and complications of meningococcal meningitis
    • Recognize high-risk groups (e.g., 16-23 years of age) and describe the importance of immunizing them
    • Describe present meningococcal vaccination recommendations, and apply them to patient cases
    • Describe the importance of vaccine series completion to patients in the prevention of invasive meningococcal disease caused by various serotypes
    • Formulate an approaches to engaging with adolescents and young adults regarding meningococcal vaccination

    Target Audience:

    The following HCPs: primary care physicians, pediatricians, and public health professionals; physician assistants, nurse practitioners, nurses, and pharmacists who practice in family medicine; and any other clinicians with an interest in or who commonly encounter patients eligible for vaccination against meningococcal disease.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 9/24/19
    • Expiration of CME credit: 9/24/21
  • FREE

    CME: HIV Prevention: The Role of Pre-Exposure Prophylaxis (HIV-PrEP)

    The development of antiretroviral therapy (ART) has had a dramatic impact on HIV-related morbidity and mortality. The use of ART in HIV-infected patients has been the core strategy to not only treat HIV but also prevent vertical HIV transmission. Antiretrovirals can be used for HIV prevention in patients who are not HIV-infected but are repeatedly exposed to HIV in a strategy termed pre-exposure prophylaxis (PrEP). Although the rationale for PrEP stems from successful HIV prevention in HIV exposed infants with the use of ART during labor, early post-partum period, and throughout breastfeeding, it has more recently applied to been applied to sexual transmission (e.g., people with multiple partners or HIV serodiscordant couples) and people who inject drugs illicitly with support from the literature. Because much of what comprises evidence and guidelines supporting PrEP has been published relatively recently and because healthcare professionals are oftentimes unable to keep up with the steady publishing of literature and evolution of clinical practice in a timely manner, continuing healthcare education activities in this area are warranted.

    By the end of the session the participant will be able to:

    • Define the role of pre-exposure prophylaxis (PrEP) including identification of high-risk patient populations for appropriate use
    • Analyze the data that support the use of PrEP for the prevention of HIV infection and apply it to patient cases
    • Assess the safety and efficacy of PrEP in the context of the medical literature and apply that knowledge to patient cases
    • Describe recommendations for PrEP use and the limitations to PrEP, and apply them to patient cases
    • Recall the economic impact of the widespread use of PrEP including benefits and limitations

    Target Audience: The following healthcare professionals: infectious disease specialists, primary care physicians, and public health; physician assistants, nurse practitioners, nurses, and pharmacists who practice in infectious disease; and any other healthcare professionals with an interest in or who clinically encounter HIV.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 9/23/19
    • Expiration of CME credit: 9/23/21